Abstract
The optimal management of instent restenosis has yet to be fully clarified. Drug eluting balloons are a popular strategy, but a new stent is preferred when dilatation gives a suboptimal result because of insufficient extrusion of neointimal tissue. There is concern for adding multiple permanent metallic layers to the vessel wall, especially in small vessels. The use of bioabsorbable vascular scaffolds appears an appealing alternative strategy, since it scaffolds the neointimal tissue without further adding metal struts to the vessel wall.
Keywords:
Bioabsorbable vascular scaffold; In stent restenosis; Neoatherosclerosis.
Copyright © 2014 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Absorbable Implants
-
Aged, 80 and over
-
Angioplasty, Balloon, Coronary / adverse effects*
-
Angioplasty, Balloon, Coronary / methods
-
Anticoagulants / therapeutic use
-
Coronary Angiography / methods
-
Coronary Artery Bypass / adverse effects*
-
Coronary Artery Bypass / methods
-
Coronary Circulation / physiology
-
Coronary Restenosis / diagnostic imaging
-
Coronary Restenosis / therapy*
-
Coronary Stenosis / diagnostic imaging
-
Coronary Stenosis / therapy
-
Follow-Up Studies
-
Humans
-
Male
-
Metals / adverse effects
-
Middle Aged
-
Neointima / diagnostic imaging*
-
Neointima / pathology
-
Neointima / physiopathology
-
Prosthesis Failure*
-
Retreatment
-
Risk Assessment
-
Sampling Studies
-
Stents / adverse effects
-
Time Factors
-
Tissue Scaffolds*
-
Treatment Outcome
-
Vascular Patency / physiology